Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

INOVIQ - Weaponising Exosomes for Breast Cancer treatment (ASX:IIQ)

- Successful Proof of Concept weaponizing exosomes for breast cancer treatment - Advancing optimisation of dosing and anti-tumour activity of exosomes Future milestones are further in vitro data...read more

INOVIQ - Quarterly Business Update and Appendix 4C - September 2024 (ASX:IIQ)

Lodging this quarterly update, Chairman David Williams said: “Progress continued across our commercial, development and corporate activities. Promega is gaining new EXO-NET customers and there...read more

INOVIQ - Appendix 4E and Preliminary Financial Report (ASX:IIQ)

To view the appendix, download the attached PDF.

INOVIQ - NEURO-NET validated in Parkinson's (ASX:IIQ)

INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce that it has further validated its NEURONET ™ technology for isolation of brain-derived exosomes in Parkinson’s Disease (PD)...read more

INOVIQ - Quarterly Activities Report and Appendix 4C - June 2024 (ASX:IIQ)

Lodging this quarterly update, Chairman David Williams said: “Our recent capital raise of $9.4m plus attaching options is evidence of the value shareholders place on the prospects of our ...read more

INOVIQ - Successful completion of Share Purchase Plan (ASX:IIQ)

Highlights: -- IIQ successfully completed its share purchase plan with applications totalling A$7.293 million, exceeding its initial target of A$2 million. -- Directors exercised discretion...read more

INOVIQ lodges SPP and Options Prospectus (ASX:IIQ)

INOVIQ Limited (ASX: IIQ) (INOVIQ or the Company) is pleased to announce that it has successfully completed the issue of 13,500,000 placement shares to institutional and sophisticated investors toda...read more

INOVIQ - Investor Presentation (ASX:IIQ)

To view the presentation, download the attached PDF.

INOVIQ isolates brain-derived exosomes in Alzheimer's (ASX:IIQ)

INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce that its NEURO-NET™ technology can isolate brain-derived exosomes in Alzheimer’s Disease. NEURO-NET captures exosomes secrete...read more

INOVIQ completes $7m placement (ASX:IIQ)

Highlights: -- INOVIQ successfully completed a A$7 million placement to institutional and sophisticated investors1 at A$0.50 per share. -- INOVIQ Board and Management have participated in the...read more

INOVIQ - Breakthrough Exosome Therapy (ASX:IIQ)

INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce that it has successfully produced and isolated engineered exosomes (EEVs) that target and kill breast cancer cells in vitro. In a proof-o...read more

INOVIQ - Quarterly Activities Report and Appendix 4C - March 2024 (ASX:IIQ)

In lodging the quarterly business update, new Chairman David Williams said “IIQ has a unique offering that is partly de-risked by having its technology launched in the market. Better still, st...read more

INOVIQ - Ovarian Cancer Test Validation (ASX:IIQ)

INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce the successful completion of an analytical validation study for its blood test for ovarian cancer. Overall, the test correctly identified 85...read more

INOVIQ Investor Update (ASX:IIQ)

To view the presentation, download the attached PDF.

INOVIQ and Promega sign Global EXO-NET Agreement (ASX:IIQ)

INOVIQ Ltd (ASX:IIQ) (INOVIQ) and Promega Corporation (Promega) are partnering to unlock the commercial potential of exosomes for research, diagnostic and therapeutic applications. This agreement wi...read more

Viewing: 1 - 15 of 111 Previous | Next